Европска Унија - Хрватски - EMA (European Medicines Agency)

idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - poremećaji uvođenja i održavanja spavanja - psycholeptics - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.

Европска Унија - Хрватски - EMA (European Medicines Agency)

novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Европска Унија - Хрватски - EMA (European Medicines Agency)

abbvie ltd - dasabuvir natrij - hepatitis c, kronični - antivirusni lijekovi za sustavnu uporabu - exviera je indicirana u kombinaciji s drugim lijekovima za liječenje kroničnog hepatitisa c (chc) u odraslih osoba. virus hepatitisa c (hcv) genotip određene aktivnosti .

Европска Унија - Хрватски - EMA (European Medicines Agency)

norgine b.v. - željezni maltol - anemija, nedostatak željeza - antianemijski pripravci - feraccru prikazan kod odraslih za liječenje nedostatka željeza .

Европска Унија - Хрватски - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Европска Унија - Хрватски - EMA (European Medicines Agency)

novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).

Европска Унија - Хрватски - EMA (European Medicines Agency)

ceva santé animale - pyriproxyfen, dinotefuran - Противопаразитарные lijekovi, insekticidi i repelenti druge ectoparasiticides za vanjsku primjenu, pyriproxyfen, kombinacije - mačke - prevencija i liječenje invazija buha (ctenocephalides feliz) na mačkama. jedna aplikacija sprečava buha provalama u roku od jednog mjeseca. ona također sprečava razmnožavanje buha, sprječava pojavu buha u okruženju mačka na 3 mjeseca.

Европска Унија - Хрватски - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - dijabetes mellitus, tip 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).

Европска Унија - Хрватски - EMA (European Medicines Agency)

novartis europharm limited  - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Европска Унија - Хрватски - EMA (European Medicines Agency)

n.v. organon - asenapine (as maleate)  - bipolarni poremećaj - psycholeptics - sycrest je indiciran za liječenje umjerenih do teških maničnih epizoda povezanih s bipolarnim poremećajem u odraslih osoba.